On 6-7 June, Meshalkin National Medical Research Centre in Novosibirsk hosted the XII Scientific Conference dedicated to the memory of Academician Evgeny Meshalkin, themed «Treatment of Comorbid Patients – A Look into the Future».
Modern trends require specialists with different profiles to work together to create a personalized approach to patient treatment, including those with comorbidities.
The conference brought together experts from diverse fields, including cardiology, cardiovascular surgery, neurology, neurosurgery, oncology, and radiotherapy. The event, which spanned multiple countries and cities, featured 23 breakout sessions and attracted attendees from 10 countries. Renowned specialists shared their insights and presented the latest findings in the treatment of comorbid patients.
The specialists of the Research Department of Vascular and Interventional Surgery, headed by Dr. Mikhail Chernyavsky, contributed to the scientific event with five oral presentations on the most relevant topics: minimally invasive treatment of aortic arch and thoracoabdominal aortic disease using fenestrated and branched stent grafts, as well as topical treatment strategies for patients with extended atherosclerotic lesions of the lower limb arteries and hybrid procedures in high-risk patients.
At the session «Endovascular diagnosis and treatment of cardiovascular diseases», researcher Yulia Panteleeva gave a presentation entitled «Thoracoabdominal aneurysms: endovascular or open surgery?» in which she shared the experience of Almazov Centre vascular surgeons in endovascular treatment of one of the most complex aortic diseases – thoracoabdominal and juxtarenal aneurysms.
The session, entitled «Optimal approaches to revascularization of peripheral arteries», presented the experience of modern endovascular treatment of patients with aortoiliac occlusive disease using a new technique of peripheral stent grafts. In addition, a patient-oriented approach to the treatment of femoropopliteal lesions was demonstrated. The breakout session on aortic surgery demonstrated the experience of Almazov Centre vascular surgeons in endovascular treatment of aortic arch disease.
Scientific events facilitate the collaboration of specialists from diverse geographical locations, including our own country. They also encourage the advancement of scientific research and the development of innovative approaches to the treatment of comorbid patients. Such conferences provide a valuable opportunity for sharing experiences with colleagues, which in turn benefits the wider scientific community. This ultimately serves as a catalyst for future scientific progress in cardiovascular surgery in Russia.